Tickers — H

34 tickers
Ranks this page's recent reports by score.
Robinhood Markets, Inc.
HOOD·Financials
A ★★★★Buy
Current$86.56
Target$120.00
Return+38.6%
Aug 1, 2026

Robinhood has successfully transitioned from a single-product retail brokerage into a highly diversified financial ecosystem capable of absorbing the immense intergenerational wealth transfer through its TradePMR RIA acquisition and explosive prediction market scaling.

Score
85
Hilton Worldwide Holdings Inc.
HLT·Consumer Discretionary
B ★★★Hold
Current$322.43
Target$360.00
Return+11.7%
Jul 31, 2026

Hilton operates a flawless asset-light compounding machine generating massive cash flow via its 243M-member loyalty network, but a premium 28x EV/EBITDA multiple warrants a Hold.

Score
84
Hudbay Minerals Inc.
HBM·Materials
A ★★★★Buy
Current$21.55
Target$33.21
Return+54.1%
Jul 30, 2026

Hudbay offers unparalleled operating leverage to copper and gold with negative cash costs and zero net debt, perfectly positioning it to fund its generational Copper World growth pipeline.

Score
92
Houlihan Lokey, Inc.
HLI·Financials
C ★★Sell
Current$139.08
Jul 31, 2026

The firm commands an elite, capital-light advisory moat with a counter-cyclical restructuring engine, but a severe freeze in software M&A and a premium valuation mandate avoiding the stock until earnings momentum recovers.

Score
73
Hilltop Holdings Inc.
HTH·Financials
A ★★★★Buy
Current$39.81
Target$45.30
Return+13.8%
Jul 30, 2026

Hilltop offers fortressed capital safety and highly accretive share buybacks driven by a booming Texas commercial bank, counterbalanced only by the cyclical drag of its struggling mortgage origination unit.

Score
85
HCI Group, Inc.
HCI·Financials
A ★★★★Buy
Current$179.27
Target$240.00
Return+33.9%
Jul 30, 2026

An extraordinarily profitable, tech-enabled insurer trading at deep value with a massive hidden asset (Exzeo), weighed against the perpetual, binary risk of a catastrophic Florida hurricane strike.

Score
91
HNI Corporation
HNI·Industrials
A ★★★★Buy
Current$44.10
Target$65.00
Return+47.4%
Jul 30, 2026

HNI's transformative $1.9 billion acquisition of Steelcase offers massive synergy potential and deep undervaluation, though integration execution risks require careful monitoring alongside macro housing headwinds.

Score
88
HealthEquity, Inc.
HQY·Healthcare
A ★★★★Buy
Current$97.84
Target$118.00
Return+20.6%
Jul 30, 2026

HealthEquity’s dominant market scale and proactive Treasury hedging ensure massive margin expansion and free cash flow generation, though impending Federal Reserve rate cuts could momentarily threaten the perceived growth trajectory of its lucrative custodial yield segment.

Score
88
Highwoods Properties, Inc.
HIW·Real Estate
B ★★★Hold
Current$33.32
Target$38.00
Return+14.0%
Jul 29, 2026

Highwoods balances a strong Sunbelt portfolio and high dividend yield against the structural headwinds of hybrid work.

Score
80
Hancock Whitney Corporation
HWC·Financials
B ★★★Hold
Current$76.20
Target$85.00
Return+11.5%
Jul 29, 2026

Hancock Whitney operates an elite, overcapitalized Gulf South deposit franchise poised for structural wealth management growth in Florida, though near-term upside is capped by industry-wide deposit funding pressure.

Score
82
H World Group Limited
HTHT·Consumer Discretionary
A ★★★★Buy
Current$40.62
Target$53.80
Return+32.4%
Jul 27, 2026

H World Group pairs a highly scalable, high-ROIC asset-light franchise machine with an attractive 5% yield, though near-term upside remains tethered to stabilizing domestic consumer RevPAR metrics.

Score
87
HCA Healthcare, Inc.
HCA·Healthcare
B ★★★Hold
Current$382.19
Target$425.00
Return+11.2%
Jul 27, 2026

An unmatched, highly profitable acute-care monopoly violently aggressively shrinking its share count, currently paralyzed by a billion-dollar regulatory headwind as millions of patients are purged from insurance exchanges.

Score
82
Hormel Foods Corporation
HRL·Consumer Staples
B ★★★Hold
Current$25.31
Target$28.00
Return+10.6%
Jul 27, 2026

Hormel Foods pairs a pristine 59-year dividend aristocrat legacy and strong brand moat with near-term margin recovery potential, though a premium valuation compared to peers warrants a Hold recommendation while interim leadership executes the portfolio transformation.

Score
76
Huntington Bancshares Incorporated
HBAN·Financials
B ★★★Hold
Current$17.36
Target$21.85
Return+25.9%
Jul 26, 2026

Huntington offers an elite 17.5% ROTCE and massive upside from Cadence synergies, but near-term upside is capped by creeping nonperforming assets and the heavy burden of absorbing 40% historical share dilution.

Score
84
Honeywell International Inc.
HON·Industrials
A ★★★★Buy
Current$246.27
Target$275.00
Return+11.7%
Jul 26, 2026

An elite automation leader wielding ultimate switching costs to monopolize the data center and energy transition boom, whose only flaw is the short-term valuation burden of a 30x forward P/E.

Score
85
The Hartford Insurance Group, Inc.
HIG·Financials
S ★★★★★Strong Buy
Current$140.53
Target$165.00
Return+17.4%
Jul 26, 2026

The Hartford offers an irresistible combination of elite commercial underwriting profitability and a relentless $4.2 billion share cannibalization engine, though investors must monitor the creeping threat of social inflation on its general liability reserves.

Score
97
Hub Group, Inc.
HUBG·Industrials
F Avoid
Current$51.23
Jul 25, 2026

Hub Group commands a resilient, under-leveraged balance sheet and a defensive intermodal network, but the unprecedented multi-year accounting fraud, decimated management credibility, and the existential ticking clock of the Nasdaq delisting deadline render the equity utterly toxic until the forensic audit is resolved.

Score
31
Hayward Holdings, Inc.
HAYW·Industrials
B ★★★Hold
Current$14.43
Target$17.40
Return+20.6%
Jul 25, 2026

Hayward is an elite, high-margin compounder dominating the highly resilient pool aftermarket, but its premium valuation leaves little room for error against the severe macroeconomic freeze in new housing and discretionary remodels.

Score
75
Halliburton Company
HAL·Energy
B ★★★Hold
Current$35.24
Target$43.44
Return+23.3%
Jul 23, 2026

Exceptional free cash flow and aggressive shareholder returns offer fundamental stability, but stagnant North American activity and intense cyclical sensitivity cap near-term multiple expansion.

Score
84
Humana Inc.
HUM·Healthcare
B ★★★Hold
Current$400.00
Target$450-$500
Jul 21, 2026

Humana possesses the demographic tailwinds and primary care infrastructure to dominate the Medicare Advantage sector long-term, but near-term exposure to uncontrollable medical utilization spikes mandates a 'Hold' stance until margin stabilization is empirically proven.

Score
76